← Back to Search

Corticosteroid

H.P. Acthar Gel SQ injection for Psoriatic Arthritis

Phase 4
Waitlist Available
Research Sponsored by Fiechtner, Justus J., M.D., P.C.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

Psoriatic arthritis is a heterogeneous chronic inflammatory disorder involving joints, tendon sheaths, entheses, and the axial skeleton as well as skin and nails. This is an open-label trial with H.P. Acthar Gel (80 units/1mL) Subcutaneous injection administered twice weekly. To evaluate the signs and symptoms of psoriatic arthritis after 12 weeks, including American College of Rheumatology 20,Clinical Disease Activity Index, Disease Activity Index 28, Dactylitis and adverse events.

Eligible Conditions
  • Psoriatic Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ACR20 (American College of Rheumatology 20)
Secondary outcome measures
Adverse Events
Other outcome measures
Clinical Disease Activity Index (CDAI)
Dactylitis (Digit Inflammation)
Disease Activity Index 28 (DAS28)

Trial Design

1Treatment groups
Experimental Treatment
Group I: H.P. Acthar Gel SQ injectionExperimental Treatment1 Intervention
Open-label H.P. Acthar Gel 80 units subcutaneously twice weekly for 12 weeks with a 12 week extension.

Find a Location

Who is running the clinical trial?

MallinckrodtIndustry Sponsor
201 Previous Clinical Trials
16,218 Total Patients Enrolled
1 Trials studying Psoriatic Arthritis
10 Patients Enrolled for Psoriatic Arthritis
Fiechtner, Justus J., M.D., P.C.Lead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
2013. "Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01939132.
All > Acth > Psoriatic Arthritis
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top